Liver cancer
hideLiver cancer is a cancer that starts in the liver. For a thorough understanding of liver cancer it is important to know a brief summary of how the liver works and functions. The liver is the largest organ in the body. It is located below the right lung and under the ribcage. The liver is divided into two lobes: the right lobe and left lobe. Protein is obtained by the liver from a set of sources. The portal vein carries nutrient rich blood from the intestines to the liver and the hepatic artery supplies the liver with blood that is rich in oxygen. Multiple types of tumors can develop in the liver because the liver is made up of many various cells. Tumors that are cancerous are termed malignant and tumors that do not contain cancer are termed benign. Liver cancer is characterized by the presence of malignant hepatic tumors -- tumors or growths on or in the liver (medical terms pertaining to the liver often start in hepato- or hepatic from the Greek word for liver, hēpar, stem hēpat-). They may be discovered on medical imaging (even for a different reason than the cancer itself), or may be present in patients as an abdominal mass, abdominal pain, jaundice, or some other liver dysfunction.
For more information about Liver cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with liver cancer
Radiology procedure may help increase long-term survival in patients with severe liver cancer
Nov 20, 2009 |
not rated yet |
0
In patients with unresectable (unable to be removed by surgery) liver cancer, an interventional radiology procedure called triple-drug transcatheter arterial chemoemobolization (TACE) followed by a liver transplant may significantly ...
Trigger of deadly food toxin discovered
Oct 21, 2009 |
4.7 / 5 (3) |
0
(PhysOrg.com) -- A toxin produced by mold on nuts and grains can cause liver cancer if consumed in large quantities. UC Irvine researchers for the first time have discovered what triggers the toxin to form, ...
Elevated lymphotoxin expression in liver leads to chronic hepatitis and causes HCC
Oct 05, 2009 |
not rated yet |
0
A recent study maps the pathway that leads from infection with Hepatitis B and C virus (HBV and HCV) to chronic hepatitis and liver cancer and proposes a new therapeutic strategy for treating liver diseases with chronic inflammation. ...
A Twist in the Genome Thwarts Hepatitis C
Sep 30, 2009 |
not rated yet |
0
(PhysOrg.com) -- Viruses like Hepatitis C proliferate by tricking cellular machinery into manufacturing the parts for duplicate viral particles.
Research isolates liver cancer stem cells prior to tumor formation
Sep 17, 2009 |
5 / 5 (1) |
0
Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer. Using ...
Cases of liver cancer reduced in a younger population vaccinated for HBV
Sep 16, 2009 |
5 / 5 (1) |
0
A 20-year follow-up study revealed a dramatic drop in liver cancer cases among 6- to 19-year-olds who were vaccinated for the hepatitis B virus at birth, according to a study published online September 16 in the Journal of ...
Current hepatitis C treatments work equally well, researchers report
Aug 07, 2009 |
not rated yet |
0
The three treatment combinations for clearing the most common form of the hepatitis C virus work equally well with similar side effects, UT Southwestern Medical Center researchers and their colleagues in 13 ...
SAMe is effective in preventing formation of primary liver cancer in rats
Jul 30, 2009 |
5 / 5 (1) |
0
A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer. SAMe, a widely available nutritional supplement, with little ...
Researchers identify genes linked to chemoresistance
Jul 20, 2009 |
5 / 5 (1) |
0
Two genes may contribute to chemotherapy resistance in drugs like 5-fluorouracil, which is used in liver cancer treatment, according to Virginia Commonwealth University Massey Cancer Center researchers.
NY hospital warns of possible hepatitis exposures
Jul 16, 2009 |
not rated yet |
0
(AP) -- A hospital in New York state is notifying about 2,800 patients of possible exposure to hepatitis C after learning that a former employee is suspected of exposing nearly 6,000 patients in Colorado to the disease.
Gene's novel role may provide key to treating liver and neurodegenerative diseases
Jul 03, 2009 |
not rated yet |
0
Scientists at Singapore's Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed ...
Study examines dietary influences of liver disease
Jul 01, 2009 |
5 / 5 (1) |
0
Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are ...
Targeting tumor behavior may lead to new liver cancer drugs
Jun 18, 2009 |
not rated yet |
1
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated ...
Good news for some hard-to-treat hepatitis C patients
Jun 16, 2009 |
not rated yet |
0
In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to ...
DKK-3 and WIF-1: Proteins related to liver cancer development?
Jun 15, 2009 |
not rated yet |
0
Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year. The current methods used to monitor such high-risk groups ...
